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Voluntary counselling, HIV testing and sexual behaviour among 
patients with tuberculosis in a rural district of Malawi
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SUMMARY
*Médecins sans Frontières, Thyolo, †National Tuberculosis Control Programme, Lilongwe, Malawi
OBJECTIVES: A study was conducted in new patients
registered with tuberculosis (TB) in a rural district of
Malawi in order to 1) verify the acceptability of volun-
tary counselling and testing for human immunodeﬁ-
ciency virus (HIV) infection; 2) describe sexual behaviour
and condom use; and 3) identify socio-demographic and
behavioural risk factors associated with ‘no condom use’.
DESIGN: Cross-sectional study.
METHODS: Consecutive patients diagnosed with TB
between January and December 2000 were offered vol-
untary counselling and HIV testing (VCT) and were sub-
sequently interviewed.
RESULTS: There were 1049 new TB patients enrolled in
the study. Of these, 1007 (96%) were pre-test coun-
selled, 955 (91%) underwent HIV testing and 912
(87%) were post-test counselled; 43 (4%) patients re-
fused HIV testing. The overall HIV infection rate was
77%. Of all HIV-positive TB patients, 691 (94%) were
put on cotrimoxazole. There were 479 (49%) TB patients
who reported sexual encounters, of whom only 6%
always used condoms. Unprotected sex was associated
with having TB symptoms for over 1 month, having had
less than 8 years of school education, being single,
divorced or widowed or having sex with the same partner.
CONCLUSIONS: Offering VCT to TB patients in this set-
ting has a high acceptance rate and provides an opportu-
nity to strengthen and integrate TB and HIV programmes.
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IN MOST COUNTRIES in sub-Saharan Africa where
human immunodeﬁciency virus (HIV) prevalence is
high, HIV has been fuelling the tuberculosis (TB) epi-
demic.1–3 Efforts to tackle tuberculosis (TB) in such
contexts have mainly focused on identifying and cur-
ing infectious TB cases among patients presenting to
the general health services. In order to effectively con-
trol TB, it is necessary not only to intensify case-ﬁnding
and decrease diagnostic and treatment delays, but
also to implement additional measures to prevent
HIV. Preventing HIV transmission in general should
contribute to reducing the overall TB burden, and this
should now be a high priority for TB control.
Malawi, a small country in central-southern Africa,
has been experiencing a severe HIV epidemic since
the 1980s, linked to which is a secondary epidemic
of TB. In 2000, a country-wide survey found that
77% of new patients registered with TB were HIV-
seropositive.4 TB may be an early opportunistic
infection that brings HIV-infected individuals to
medical attention. It is thus an opportunity for
introducing interventions linked to prevention and
care.
Since early 1999, as part of an integrated HIV/TB
strategy, all TB patients in Thyolo, a rural district in
southern Malawi, have been offered voluntary HIV
counselling and testing (VCT) as a way to promote
behaviour change and safer sexual practices.5,6 It might
also provide an opportunity to reduce HIV transmis-
sion to sexual contacts who remain HIV-negative.
VCT particularly serves as an entry point for offering
adjunctive cotrimoxazole for the prevention of oppor-
tunistic infections in HIV-infected TB patients.7,8
Good counselling requires full discussion and
understanding of sexual behaviour and condom use,
the latter being a critical measure in preventing the
sexual transmission of HIV.9 This would be relevant
in targeting preventive counselling as well as for guid-
ing condom promotion strategies within the general
population.
The present study was carried out among patients
presenting with TB in order to 1) verify the accept-
ability of voluntary counselling and HIV testing; 2)
describe sexual behaviour and condom use; and 3)
identify socio-demographic and behavioural risk fac-
tors associated with ‘no condom use’.
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MATERIAL AND METHODS
Study setting, diagnosis and treatment of TB patients
This study was conducted during a 1-year period
among all new TB patients registered between Janu-
ary and December 2000, under routine programme
conditions, in Thyolo district in rural southern
Malawi. The district has 450000 inhabitants. Two
hospitals manage TB in the district, and both were
involved in the study. In these two hospitals, TB
patients are diagnosed, registered and started on stan-
dardised anti-tuberculosis treatment according to na-
tional guidelines.10 Patients who are sputum smear-
positive for acid-fast bacilli (AFB) are classified as
smear-positive pulmonary tuberculosis (PTB). In
patients who are sputum smear-negative, a diagnosis
of smear-negative PTB is made for those with radio-
graphic abnormalities consistent with TB. The diag-
nosis of extra-pulmonary TB (EPTB) is usually made
on the basis of clinical features, radiographic appear-
ances and laboratory-based examination of serous
ﬂuid.
Those with smear-positive PTB and serious forms
of EPTB were given an 8-month regimen consisting of
2 months of daily supervised streptomycin (S), rifam-
picin (R), isoniazid (H) and pyrazinamide (Z) in hos-
pital followed by 6 months of daily unsupervised H
and ethambutol (E) in the community (2SRHZ/6HE).
New patients with smear-negative PTB and less seri-
ous forms of EPTB were given a 12-month regimen
consisting of 1 month of daily supervised SHE in hos-
pital followed by 11 months of daily self-administered
HE (1SHE/11HE). The initial phase of treatment was
always administered in hospital, and the continuation
phase in the community.
Integrated VCT, cotrimoxazole prophylaxis
and referral to home-based care
All patients, once registered and started on standard-
ised anti-tuberculosis treatment, are referred to the
hospital’s HIV VCT unit, where pre-test counselling
is given. This involves giving basic information about
HIV and the acquired immune-deﬁciency syndrome
(AIDS) and its prevention, explaining the reasons for
recommending the HIV test and the patient’s right to
refuse the test. Patients who accepted HIV testing
were also offered post-test counselling. If the test was
negative for HIV, the patient was given information
on how to avoid contracting HIV and AIDS (primary
preventive counselling). If the test was positive, the
patient received information on how to prevent re-
infection and transmission to partner(s), and on con-
dom use (secondary preventive counselling). Partner
counselling was encouraged, and patients had access
to same day test results. All blood samples were
screened for HIV-1 and HIV-2 using a combination of
two rapid tests, the Capillus (Cambridge Diagnostics
Ltd, Galway, Ireland) and HIV-Spot (Genelabs Diag-
nostics, Singapore) tests. All tests were performed
according to the manufacturers’ instructions. The
choice of tests conformed with the World Health
Organization (WHO) strategy II for HIV antibody
testing.11 Any discordant sample was retested, and if
it remained discordant was sent for enzyme-linked
immunosorbent assay (ELISA) testing at the referral
hospital in Blantyre.
Patients who tested HIV-seropositive were also
offered adjunctive cotrimoxazole at the time of post-
test counselling, provided there were no contraindica-
tions to the medication. Cotrimoxazole was given at a
dose of 480 mg (400 mg sulphamethoxazole and 80
mg trimethoprim) twice daily for the whole course of
anti-tuberculosis treatment, and indeﬁnitely there-
after. Anti-tuberculosis drugs and both daily doses of
cotrimoxazole were administered by direct observa-
tion during the initial phase of treatment. In the con-
tinuation phase, anti-tuberculosis drugs and cotrimox-
azole were collected by patients at monthly intervals
from their nearest health facility, and the drugs were
self-administered. After anti-tuberculosis treatment,
patients were encouraged to continue with cotrimox-
azole prophylaxis, which is provided free of charge at
the health centres.
At the end of the initial phase, all patients once
again visit the counselling unit for reinforcing coun-
selling messages. The counselling unit also refers all
TB patients to a trained network of community-based
volunteers who manage basic opportunistic infections
(for those patients who are HIV-positive) and provide
social support for all those who might require it.
Trained volunteers are provided with a home-based
care (HBC) kit containing basic drugs for opportunis-
tic infection management, and supportive material
for care. The community network also has an active
association of people living with AIDSs (PLWA) who
are involved with community mobilisation and
awareness. The network also offers orphan care,
vocational training, income generation activities and
nutritional support for individuals within HIV/TB-
affected households.
Anti-retroviral treatment is currently not available
for HIV-infected TB patients in Malawi.
Data collection and statistical analysis
Counselling unit registers were used for gathering
information on the counselling process, HIV status and
cotrimoxazole uptake. The TB register was used to
gather information on TB type, while a semi-structured,
pre-tested questionnaire was used to gather informa-
tion on basic socio-demographic data, duration of TB
symptoms, sexual behaviour and previous medica-
tion. All TB patients were interviewed after obtaining
informed consent. Interviews were conducted in the
local language in the counselling unit by the HIV
counsellors, and the same team was used throughout
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The TB symptomatic period (rather than a ﬁxed
calendar time period) was used to gather information
on sexual behaviour. Symptoms included cough, dif-
ﬁculty in breathing, chest pain, weight loss, night
sweats or lymph gland enlargement.
‘Same partner’ was deﬁned as ‘spouse’ or a steady
sexual partner over a period of at least 6 months prior
to the interview.
Analysis was done using Epi-Info (Centre for Dis-
ease Control and Prevention, Atlanta, GA) and Logis-
tic software.12 The measures of risk were determined
by crude and adjusted odds ratios (OR). ORs were
adjusted using multivariate logistic regression, and all
related P values are based on the likelihood ratio sta-
tistic. ‘No condom use’ during sexual encounters was
designated as the dependent variable for identifying
potential risk associations. This group of people who
never use condoms (as against those who use con-
doms intermittently) were selected a priori, as they
are more likely to represent complete operational
gaps or barriers in condom promotion, accessibility
or acceptability in the district.
The level of signiﬁcance was set at P   0.05 or
less and 95% conﬁdence intervals (CI) were used
through out.
RESULTS
Characteristics of the study population
There were 1049 new TB patients who were regis-
tered during the study period. This included 483
(46%) patients with smear-positive PTB, 336 (32%)
with smear-negative PTB and 231 (22%) with EPTB.
Of these, 64 patients were excluded from the ques-
tionnaire part of the study: 34 patients did not want
to participate in the interview, four died before inter-
views could be conducted, and 26 questionnaires were
incomplete. Of the 985 patients whose data were com-
plete, there were 503 men and 482 women (49%),
with a median age of 32 years (range 11–82) and a
median educational level of 6 years (range 0–13) in
school. There were 248 patients who were married,
while 737 (75%) were either unmarried, divorced or
widowed. The commonest occupations were farming
in 526 (53%), unskilled work in 189 (19%), skilled
work in 105 (11%) and business in 136 (3%) patients.
The majority of patients (94%) resided in villages,
with 62% earning less than 4 USD per week. The
median period spent with TB symptoms prior to diag-
nosis was 56 days (range 9–365). Nine hundred
and sixty-ﬁve (98%) patients had received medica-
tion from either a traditional healer or from the
private health sector before commencing anti-
tuberculosis treatment.
Voluntary counselling and HIV testing
Of the 1049 new TB patients, 1007 (96%) were pre-
test counselled, 955 (91%) underwent HIV testing
and 912 (87%) were post-test counselled. Thirteen
(1%) patients refused pre-test counselling, 43 (4%)
refused HIV testing, and eight refused to know their
HIV results after accepting to be tested for HIV (Figure).
Of the 955 TB patients who were HIV tested, 735
(77%) were HIV-positive: this included 294 (67%) of
439 smear-positive PTB patients, 252 (85%) of 296
smear-negative PTB patients and 189 (86%) of 220
EPTB patients. The mean period between registration
for TB and post-test counselling was 3 days. Of all
partners of HIV-infected TB patients, 60% accepted
VCT and a family relative was involved (along with
the patient) in 89% of post-test counselling sessions.
Of those who were post-test counselled, 691 (97%),
94% of all HIV-positive TB patients, were eventually
placed on cotrimoxazole following VCT.
Sexual behaviour and risk factors
associated with ‘no condom use’
Of all TB patients, 479 (49%) reported having had
sex during the period of TB symptoms, of whom
356 (74%) were HIV-seropositive. Table 1 shows
sexual behaviour and condom use in relation to
HIV status. Of the 31 (13%) patients who had
never heard of condoms, 90% resided in villages;
87% of those who used condoms intermittently
were HIV-positive compared to 73% of those who
never used condoms (OR 2.5, 95%CI 1.5–4.2, P  
0.001).
Signiﬁcant risk factors associated with ‘no condom
Figure Voluntary counselling and HIV testing in TB patients.68 The International Journal of Tuberculosis and Lung Disease
use’ in TB patients include being single/divorced or
widowed, having had less than 8 years of school edu-
cation, having had TB symptoms for over 1 month
and having sexual encounters with the same partner
(Table 2).
DISCUSSION
This study shows that in a rural district of Malawi
there is a high acceptance rate for VCT and cotrimox-
azole prophylaxis among TB patients, of whom
Table 1 Sexual behaviour and condom use in relation to human immunodeﬁciency virus








Total 727 (78) 208 935*
Sex during TB symptomatic period   yes 356 (79) 96 452
With same partner 208 (74) 73 281 (62)
With different partners 148 (87) 23 171 (38)
Condom use during sex (n   452)
Always 20 (71) 8 28 (6)
Intermittent/sometimes 171 (87) 26 197 (44)
No condom use 165 (73) 62 227 (50)
Reasons for ‘no condom use’ (n   227)
Sex with the same partner 104 (72) 41 145 (64)
Refusal by partner 9 (60) 6 15 (7)
Condom not available 11 (73) 4 15 (7)
Reduces pleasure 14 (82) 3 17 (8)
Religious reasons 3 (75) 1 4 (2)
Did not know about condoms 24 (77) 7 31 (14)
*HIV status was unknown for 50 TB patients.
Table 2 Risk factors associated with ‘no condom use’ in TB patients reporting sex (n   479)
Variables





Men 126/266 (47) 1 1
Women 111/213 (52) 1.2 0.8 (0.5–1.2) 0.26
Age
 20 years 222/452 (49) 1 1
 20 years 15/27 (56) 1.3 2.0 (0.8–5.4) 0.15
Marital status
Married 29/115 (25) 1 1
Single/divorced/widowed 208/364 (57) 4.0 3.1 (1.8–5.3)  0.001
Residence
Semi-urban towns 31/97 (32) 1 1
Villages 206/381 (54) 2.5 1.3 (0.7–2.4) 0.32
Education
 8 years 35/128 (27) 1 1
 8 years 202/351 (58) 3.6 2.1 (1.3–3.7)  0.01
Occupation
Non farmers 101/242 (42) 1 1
Farmers 136/237 (57) 1.9 (0.6–1.8) 0.94
Income
 4 USD/week 90/226 (40) 1 1
 4 USD/week 147/253 (58) 2.1 1.3 (0.8–2.1) 0.27
Period of TB symptoms
 1 month 75/215 (35) 1 1
 1 month 162/264 (61) 3.0 2.1 (1.3–3.2)  0.01
TB type
Smear negative TB/EPTB 125/271 (46) 1 1
Smear positive TB 112/208 (54) 1.4 1.3 (0.9–2.0) 0.22
Partners
Different partner 47/182 (26) 1 1
Same partner 190/297 (64) 5.1 5.3 (3.4–8.3)  0.001
*Adjusted for sex, age, marital status, residence, education, occupation, income, period of symptoms, TB type and
partners.
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approximately three-quarters are HIV-seropositive.
Of the TB patients who had sexual intercourse, 50%
had never used condoms. ‘No condom use’ was more
common in those with a long duration of TB symp-
toms, a short period of school education, being single/
divorced or widowed and having sex with the same
partner.
Studies in Africa have shown the efﬁcacy of VCT
in promoting behaviour change and safer sexual prac-
tices, and it appears to be a cost-effective intervention
to reduce the sexual transmission of HIV.5,6 Our
experience with VCT among TB patients in the rural
programme setting is very encouraging, for a number
of reasons. First, it has been possible to integrate VCT
services within the framework of routine TB control,
and the acceptance rate for VCT is high, with only
1% of all TB patients refusing pre-test counselling
and 4% refusing HIV testing. Successful integration
of VCT services within a national TB programme has
also been reported in Côte d’Ivoire.13 Second, it has
offered us the opportunity to introduce systematic
HIV-preventive counselling for all TB patients and to
offer cotrimoxazole prophylaxis for those found to be
HIV-positive.7 The uptake of cotrimoxazole has also
been high, with 94% of all HIV-positive TB patients
being placed on prophylaxis. High compliance with
cotrimoxazole prophylaxis 4 to 6 months after start-
ing anti-tuberculosis treatment has been demonstrated
previously in our setting.14 Third, good links have been
established between hospital counselling services and
community care groups. This has made it possible to
refer HIV-infected individuals to the community for
continuing social and nutritional support, home-based
care and the management of basic opportunistic infec-
tions. Anti-retroviral treatment is currently not avail-
able for HIV-infected TB patients in Malawi. However,
such a network that offers a package of basic care,
chemoprophylaxis and support is a step towards provi-
sion of comprehensive HIV care, including the possible
introduction of anti-retroviral therapy into the system.
The high uptake of VCT in our setting might be
due to a number of reasons. First, VCT is fully inte-
grated into the TB circuit and offered to all TB
patients systematically, thereby reducing the possibil-
ity of stigma for any particular patient. Second, the
VCT unit is well staffed with trained counsellors, has
adequate space to ensure privacy and offers rapid HIV
testing. This enhanced privacy and averted undue
delays. Third, VCT serves as the entry point to access-
ing cotrimoxazole prophylaxis as well as referral to the
network of community volunteers who provide con-
tinuing care and social support. In a resource-poor set-
ting, where effective and affordable interventions to
reduce morbidity and mortality in HIV-positive indi-
viduals are limited, it is likely that access to cotrimox-
azole as well as a network of community volunteers
who provide care and social support would act as
incentives for VCT.
The high uptake of cotrimoxazole prophylaxis in
our setting might also be related to the quality of
VCT services and the eventual value of the drug as
perceived by the patient. In our setting we also use the
CARE model approach in counselling.15 This requires
that the spouse, a close relative or ‘signiﬁcant other’ is
involved in the counselling process. This enhances
understanding and support for the patient at home,
and limits the problems associated with disclosure
and loss of conﬁdentiality when taking pills on a daily
basis.
The main obstacle to setting up VCT and cotri-
moxazole prophylaxis in our setting was the lack of
human and ﬁnancial resources. This was overcome by
increasing the capacity and numbers of available human
resources, and providing the additional funds required
for training, supervision and the purchase of rapid tests
and cotrimoxazole. The additional resources were pro-
vided by the supporting non-governmental organisa-
tion, Médecins sans Frontières.
In gathering information on sexual behaviour, we
used the period of TB symptoms rather than a ﬁxed
calendar time period, ﬁrstly because the longer the
period of TB symptoms prior to presentation to hos-
pital VCT services (and hence to primary and second-
ary HIV preventive counselling), the greater is the
potential for high risk sexual behaviour and therefore
for acquiring or transmitting HIV to partners who
might be uninfected. Knowledge about sexual behav-
iour during the TB symptomatic period would there-
fore reinforce the relative importance of encouraging
early presentation to hospital and VCT services. Sec-
ondly, we did not intend to collect speciﬁc informa-
tion on the frequency of sexual episodes and number
of sexual partners (in which case a standard time
period would be necessary), but rather general infor-
mation on sexual behaviour as related to type of part-
ner(s) and condom use. One of the limitations of our
approach is that the TB symptomatic period will vary
to a certain extent between individuals, and might, as
a result of the variable period of sexual risk, intro-
duce differential recall bias.
In our study, patients spent a median period of 56
days (2 months) with TB-related symptoms before
presenting at the hospital. Those who had symptoms
for long periods and were HIV-positive were also at
higher risk of not using condom during sexual en-
counters. Community awareness campaigns and closer
collaboration with alternative care providers are
required in order to bring patients into early contact
with VCT services (which offer primary and second-
ary HIV preventive counselling) and to institute early
and effective anti-tuberculosis treatment. Reducing
treatment delays will also have an effect on reducing
the overall risk of TB transmission to people living
with HIV in the community.1–3
A high proportion (51%) of the TB patients in our
study were not sexually active. It is possible that TB70 The International Journal of Tuberculosis and Lung Disease
patients might simply be weak as a result of the illness
and are hence sexually inactive. Perceptions of sex
while having TB might also be important. Another
study in Malawi showed that 58% of TB patients
country-wide believed that it was necessary to abstain
from sexual intercourse during TB treatment.16
HIV prevalence in those who used condoms inter-
mittently was signiﬁcantly higher than in those who did
not use them at all. The majority of those who
reported ‘no condom use’ had sex with the same part-
ner and are likely to have a smaller sexual network
than those who report intermittent condom use. The
latter group might have a larger sexual network and
may use condoms as they perceive themselves at risk,
but yet are unable to always negotiate condom use.
The great majority of our TB patients reside in vil-
lages and have had less than 6 years of school educa-
tion. Information, education and communication
(IEC) strategies on safer sexual behaviour in Malawi
have often concentrated on urban areas and the use of
written media (boards, posters, etc), which are not
adapted for less literate rural populations. There is
now an urgent need for socio-culturally adapted,
intensive and sustained educational campaigns that
can bridge knowledge gaps and promote safer sex
among rural populations.
One of the general limitations of the study is that
the information on sexual behaviour and condom use
is self-reported, and that too in TB patients that are
predominantly sick with TB and already HIV-infected.
We tried to minimise this by ensuring that the inter-
views were conducted by well-trained and experi-
enced HIV counsellors who were conversant with the
approach on sexual issues within the particular pop-
ulation. Interviews were readily rescheduled by the
interviewers if the patient felt uneasy or appeared
unready for whatever reason to respond to the
requested information at any particular time.
This study demonstrates high clinical coverage
with VCT and cotrimoxazole among TB patients who
are a high-risk group for HIV. Offering VCT to TB
patients who are predominantly HIV-positive pro-
vides an excellent opportunity for strengthening and
integrating HIV and TB control activities as well as
for introducing interventions for prevention and care.
What is now needed is the political and social will as
well as the resources to make VCT available to the
vast numbers of people with little or no access to it.
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RÉSUMÉ
OBJECTIF: Cette étude a été menée chez des nouveaux
patients enregistrés comme tuberculeux (TB) dans un
district rural du Malawi, afin : 1) de vérifier l’acceptabi-
lité de l’accompagnement volontaire et du test pour le
virus de l’immunodéficience humaine (VIH) ; 2) de dé-
crire le comportement sexuel et l’utilisation des préserva-
tifs ; et 3) d’identifier les risques socio-démographiques et
comportementaux associés avec l’absence d’utilisation
du préservatif.
SCHÉMA : Etude transversale.
MÉTHODES: Patients consécutifs diagnostiqués comme
tuberculeux entre janvier et décembre 2000 auxquels on
a offert un accompagnement volontaire et un test VIH
(VCT) et qui ont subi ultérieurement une interview.
RÉSULTATS: L’étude a permis d’enrôler 1.049 nouveaux
patients TB. Parmi ceux-ci, 1.007 (96%) ont bénéficié
d’un accompagnement pré-test, 955 (91%) ont eu un
test VIH et 912 (87%) ont eu un accompagnement post-
test. Le test VIH a été refusé par 44 patients (4%). Le
taux global d’infection par le VIH a été de 76%. On a
placé sous cotrimoxazole 691 patients TB, représentant
94% de l’ensemble des patients TB séropositifs pour le
VIH. Des relations sexuelles ont été signalées par 479
patients TB (49%), dont 6% seulement utilisaient tou-
jours les préservatifs. On a noté que les rapports sexuels
non protégés étaient associés avec le fait d’avoir des
symptômes TB depuis plus d’un mois, avec celui d’avoir
moins de 8 ans de formation scolaire, d’être célibataire,
divorcé ou veuf ou d’avoir des relations sexuelles avec le
même partenaire.
CONCLUSIONS: Le taux d’acceptation de l’offre du VCT
aux patients tuberculeux a été très élevé dans ce contexte ;
il donne l’occasion de renforcer et d’intégrer les pro-
grammes TB et VIH.
RESUMEN
OBJETIVO: Se realizó un estudio en pacientes nuevos
registrados con tuberculosis (TB) en un distrito rural de
Malawi, para 1) verificar la aceptabilidad del acom-
pañamiento voluntario y del test del virus del inmunode-
ficiencia humana (VIH), 2) describir el comportamiento
sexual y el uso de preservativos y 3) identificar los fac-
tores de riesgo sociodemográficos y comportamentales
asociados con el no uso de preservativos.
DISEÑO : Estudio transversal.
MÉTODO: Pacientes consecutivos con diagnóstico de
TB entre enero y diciembre de 2000 a quienes se ofreció
un acompañamiento voluntario y un test VIH (VCT) y
que fueron entrevistados posteriormente.
RESULTADOS: En este estudio se enrolaron 1.049
pacientes nuevos con TB. De éstos, 1.007 (96%) tuvieron
un acompañamiento antes del test, 955 (91%) tuvieron
un test VIH y 912 (87%) tuvieron un acompañamiento
después del test. Rehusaron el test 43 pacientes (4%). La
tasa global de infección VIH fue de 77%. Se trataron
con cotrimoxazol 691 pacientes tuberculosos, lo que
representa el 94% de todos los pacientes con TB positi-
vos para el VIH. Señalaron tener relaciones sexuales 479
pacientes con TB (49%), de los cuales sólo el 6% usaban
siempre preservativos. Las relaciones sexuales no prote-
gidas estaban asociadas con la presencia de síntomas de
TB desde hacía más de un mes, con el hecho de tener
menos de 8 años de educación escolar, con el hecho
de ser soltero, divorciado o viudo o de tener relaciones
sexuales con la misma pareja.
CONCLUSIÓN: La tasa de aceptación del VCT a los
pacientes con TB fue elevada en este contexto y da la
ocasión para reforzar e integrar los programas de TB y
VIH.